Financials
- Market Capitalization 2.56 B
- Employee 177
- Founded 2006
- CEO N/A
- Website www.immunome.com
- Headquarter Delaware, United States
- FIGI BBG00BR93ZG8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-9.15
Rapporto prezzo/fatturato
112.46
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1794 | KOD Kodiak Sciences Inc - Common Stock | 43.26 USD | +5.26% | +13.96% | +26.90% | +790.12% | 2.71 B USD | ||
| 1821 | QURE uniQure N.V. - Ordinary Shares | 41.52 USD | +1.02% | +0.24% | +49.73% | +195.10% | 2.62 B USD | ||
| 1845 | TRVI Trevi Therapeutics, Inc. - Common Stock | 17.91 USD | +8.41% | -8.15% | +22.09% | +161.08% | 2.54 B USD | ||
| 1856 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.39 USD | +6.10% | -6.36% | +76.18% | +597.40% | 2.49 B USD |